(UroToday.com) The EAU Virtual 2020 meeting featured a thematic session looking at controversies in renal cancer surgery, specifically the debate of timing of cytoreductive nephrectomy. Antonio Finelli, MD, MSc, FRCSC, started by noting we should never say never, and never say always, which he feels fits perfectly to the debate of cytoreductive nephrectomy.
(UroToday.com) Dr. Inderbir Gill gave a talk on his career experience in kidney surgery. Dr. Gill’s team has performed over 5000 cases of robotic renal surgeries. His talk focused on 5 important factors to consider in kidney surgery.
(UroToday.com) As part of the cytoreductive nephrectomy debate at the 2020 European Association of Urology (EAU) Virtual Meeting, Dr. Axel Bex discussed the role of cytoreductive nephrectomy being an option only after a response to treatment. Dr. Bex notes that this talk is not focusing on patients that are being observed after upfront cytoreductive nephrectomy, but […]
(UroToday.com) As part of the thematic session on salvage lymph node dissection for prostate cancer at the annual European Association of Urology 2020 virtual meeting, Alberto Briganti, MD, from Milan, Italy discussed the role of early diagnosis in these patients. Dr. Briganti started by noting that whether early detection of nodal metastasis is helpful to the […]
(UroToday.com) Dr. Steven Joniau discussed the role of surgery as the best option for men with treatment of recurrent lymph node metastatic prostate cancer at the 2020 European Association of Urology (EAU) Virtual Meeting. Dr. Joniau notes that the location of relapse is important in relation to treatments received. Lymph node recurrence may be highly variable, […]
(UroToday.com) As part of the EAU 2020 virtual meeting, the prostate cancer session highlighted a series of talks on the primary treatment of pelvic lymph node metastatic prostate cancer. Karim Touijer, MD, MPH, discussed the role of surgery alone for these patients.
(UroToday.com) As part of the prostate cancer session at the 2020 European Association of Urology (EAU) Virtual Meeting, several presentations were given discussing the primary treatment of pelvic lymph nodes, including the radiation-only perspective provided by Dr. Nicholas van As from London, UK. According to Dr. van As radiotherapy in this scenario is attractive because it […]
(UroToday.com) As part of the immunotherapy and beyond thematic session at the virtual EAU 2020 meeting, Shahrokh Shariat, MD, discussed whether all urothelial patients should be sequenced. As he notes, urothelial carcinoma is a highly heterogeneous entity and in line with precision medicine, we must select the right therapy, for the right tumor, in the right […]
(UroToday.com) Karim Bensala, MD, Ph.D., began his talk discussing the evolution of small renal masses (SRMs). The DISSRM registry has shown that 80% of SRMs have a less than 0.5 cm/year growth rate, and 30% remain stable1 (Figure 1). 35% of SRMs do not grow at all, and there is no correlation between low growth rate […]
(UroToday.com) As part of the “Game-changing Session 4” plenary session at the European Association of Urology (EAU) Virtual Annual Meeting, Dr. Josefsson presented data from the Scandinavian Prostate Cancer Group (SPCG) trial 14, a prospective, open, multicentre, phase II clinical trial of bicalutamide alone or with the addition of docetaxel in nonmetastatic prostate cancer with a […]
